Skip to content

Clinical trials

Phase 1/2 Lung Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 1/2 Country / region: Spain Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20191
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Hoffmann-La Roche1
MediLink Therapeutics (Suzhou) Co., Ltd.1
PEACHES BIOTECH1
Revolution Medicines, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases7
Thoracic Neoplasms6
Bronchial Neoplasms5
Carcinoma, Non-Small-Cell Lung5
Colonic Neoplasms5
Lung Neoplasms5
Neoplasms5
Neoplasms by Site5
Respiratory Tract Diseases5
Respiratory Tract Neoplasms5

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.